dr. hermann frieboes - modulation of immune response to cancer via nanotherapy
Published Streamed 3 years ago • 112 plays • Length 55:08Download video MP4
Download video MP3
Similar videos
-
1:24
final phase 2 results of lcl161 for myelofibrosis
-
2:26
assessing the impact of momelotinib on transfusion burden in mf: analysis of simplify-1 & momentum
-
4:35
pathophysiology and new molecular targets of bone marrow failure
-
2:26
outcomes of patients with accelerated-phase myelofibrosis after reduced-intensity hsct
-
2:33
predicting benign disease course in ms
-
43:17
immunology lecture series-57_immune response to tumours and evasion of immune response by tumours
-
1:58
canakinumab plus darbepoetin in patients with lr-mds following esa failure
-
1:33
outcomes of reduced intensity allosct in patients with accelerated-phase myelofibrosis
-
3:36
ukall14: rituximab dose & reduced intensity transplant in b-all & nelarabine consolidation in t-all
-
6:09
significantly improving hrql and neurocognition in high-risk sickle cell following familial asct
-
7:29
research grant recipient: dr. monica bessler
-
1:13
dr. ralph kern explains how an imbalance of the immune system can cause damage to the cns
-
2:32:32
feam forum annual lecture 2020: cancer & immunotherapy
-
1:43
reasons why there are fewer treatment options for mds patients and hope for the future
-
0:56
improving therapeutic approaches for patients with ph-like all & the importance of disease biology
-
1:49
results from manifest phase ii study of pelabresib for anemia associated with myelofibrosis
-
1:55
update on the phase i/ii bruin study
-
9:20
sprifermin case study | marc hochberg